Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company MABLife S.A.S
Description mAb that specifically binds against Aspergillus fumigatus cell wall targets
Molecular Target Beta 1,3-D-glucan synthase
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationAspergillus
Indication DetailsTreat nosocomial infections
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today